Abstract
Microbes exert influence across the microbiome-gut-brain axis through neurotransmitter production, induction of host immunomodulators, or the release or induction of other microbial or host molecules. Here, we used mass spectrometry imaging (MSI), a label-free imaging tool, to map molecular changes in the gut and brain in germ-free, antibiotic-treated and control mice. We determined spatial distribution and relative quantification of neurotransmitters and their precursors in response to the microbiome. Using untargeted MSI, we detected a significant change in the levels of four identified small molecules in the brains of germ-free animals compared to controls. However, antibiotic treatment induced no significant changes in these same metabolites in the brain after 1 week of treatment. This work exemplifies the utility of MSI as a tool for the study of known and discovery of novel, mediators of microbiome-gut-brain axis communication.
Original language | English |
---|---|
Pages (from-to) | 649-659 |
Number of pages | 11 |
Journal | Journal of the American Society for Mass Spectrometry |
Volume | 33 |
Issue number | 4 |
DOIs | |
Publication status | E-pub ahead of print - 9 Mar 2022 |
Keywords
- brain
- mass spectrometry imaging
- metabolites
- microbiome
- neurotransmitters